Mahyco Monsanto Biotech (India) Private Limited ( MMB)

Mahyco Monsanto Biotech (MMB) - a 50:50 joint venture between Mahyco and Monsanto Holdings Pvt. Ltd. has sub-licensed the Bollgard II® and Bollgard® technologies to around 42 Indian seed companies each of whom have introduced the Bollgard® technologies into their own germplasm. Indian farmers have a choice of over 800 Bt cotton hybrid seeds. The rigorous scientific studies conducted in India and abroad demonstrate that Bollgard® and its products are safe for the environment, human beings, animals and agriculture.

Bollgard® Bt cotton (single-gene technology) is India’s first biotech crop technology approved for commercialization in India in 2002, followed by Bollgard® II – double-gene technology in mid-2006, by the Genetic Engineering Approval Committee (GEAC), the Indian regulatory body for biotech crops.

Bollgard® cotton provides in-built protection for cotton against destructive American Bollworm Heliothis Armigera infestations, and contains an insecticidal protein from a naturally occurring soil microorganism, Bacillus thuringiensis (Bt). Bollgard® II technology contains a superior double-gene technology - Cry1Ac and Cry 2Ab which provides protection against bollworms and Spodoptera caterpillar, leading to better boll retention, maximum yield, lower pesticides costs, and protection against insect resistance. Both, Bollgard® II and Bollgard® insect-protected cotton are widely planted around the world as an environmentally friendly way of controlling bollworms.

Learn more about the MMB India CSR policy